JESSICA BURTON: Open Payments
NPI 1225722911 · GRAND RAPIDS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 14 payments from 9 companies in 2025. Trend: 2023 $50 · 2024 $784 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| ABBVIE INC. | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Indivior Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
| Bausch Health US, LLC | 1 | $27 |
| Lundbeck LLC | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $17 |
Products named: REXULTI, VRAYLAR, COBENFY, SUBLOCADE, SPRAVATO, APLENZIN, AUSTEDO XR, LOREEV XR.
Industry payments across MN — which companies pay providers there.
